PhD Hannelore Willkommen (Head, Section of Viral Safety)
{"title":"1d病毒灭活血浆产物的病毒传播","authors":"PhD Hannelore Willkommen (Head, Section of Viral Safety)","doi":"10.1016/S0950-3501(97)80027-X","DOIUrl":null,"url":null,"abstract":"<div><p>The viral safety of virus-inactivated plasma products has been markedly enhanced by the improvement in tests for screening donations and by the improvement in techniques for manufacture of plasma derivatives including methods for virus inactivation. Nevertheless, there remains a weakness in removing inactivating heat-resistant non-enveloped viruses, such as parvovirus B19. Manufacturers' efforts should continue to be concentrated on this challenge.</p></div>","PeriodicalId":80610,"journal":{"name":"Bailliere's clinical anaesthesiology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"1997-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0950-3501(97)80027-X","citationCount":"2","resultStr":"{\"title\":\"1d Virus transmission by virus-inactivated plasma products\",\"authors\":\"PhD Hannelore Willkommen (Head, Section of Viral Safety)\",\"doi\":\"10.1016/S0950-3501(97)80027-X\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>The viral safety of virus-inactivated plasma products has been markedly enhanced by the improvement in tests for screening donations and by the improvement in techniques for manufacture of plasma derivatives including methods for virus inactivation. Nevertheless, there remains a weakness in removing inactivating heat-resistant non-enveloped viruses, such as parvovirus B19. Manufacturers' efforts should continue to be concentrated on this challenge.</p></div>\",\"PeriodicalId\":80610,\"journal\":{\"name\":\"Bailliere's clinical anaesthesiology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1997-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/S0950-3501(97)80027-X\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Bailliere's clinical anaesthesiology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S095035019780027X\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bailliere's clinical anaesthesiology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S095035019780027X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
1d Virus transmission by virus-inactivated plasma products
The viral safety of virus-inactivated plasma products has been markedly enhanced by the improvement in tests for screening donations and by the improvement in techniques for manufacture of plasma derivatives including methods for virus inactivation. Nevertheless, there remains a weakness in removing inactivating heat-resistant non-enveloped viruses, such as parvovirus B19. Manufacturers' efforts should continue to be concentrated on this challenge.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
